Method of treating airway diseases with combined administration of A2B and A3 adenosine receptor antagonists
OwnerS. Jamal Mustafainventor
Life of this patent
Estimating the term…
Abstract
Methods and compositions for treating airway diseases such as asthma and inflammation are described. The methods utilize the concurrent administration of an A3 adenosine receptor antagonist and an A2B adenosine receptor antagonist (either separately or put together chemically in a single molecule having both A3 and A2B blocking effect), for both receptor binding agents and antisense oligonucleotides. The compositions contain both an A3 adenosine receptor antagonist and an A2B adenosine receptor antagonist, together in a pharmaceutically acceptable carrier.
Claims6
A method of treating an airway disease, airway inflammation, or both an airway disease and airway inflammation in a subject in need of such treatment, comprising concurrently administering to said subject an A3 adenosine receptor antagonist and an A2B adenosine receptor antagonist, in an amount effective to treat said disease.
Dependencies are inferred from the claim text.